Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperoncotic Albumin in Cystectomy
NCT03848507Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2019
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of albumin (human), sponsored by Insel Gruppe. Primary endpoint: Plasma volume expansion at 5 hours. Started Mar 2019; status: completed.
02
Drugs
albumin (human)
Beyond the preview
Go deeper on NCT03848507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03848507.